A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity
about
Ancient and recent positive selection transformed opioid cis-regulation in humansBipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent triosAltered functional protein networks in the prefrontal cortex and amygdala of victims of suicideCis-regulatory variations: a study of SNPs around genes showing cis-linkage in segregating mouse populations.Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosisHuman NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.NEFL mRNA expression level is a prognostic factor for early-stage breast cancer patients.Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression.Genetic Association of NPY Gene Polymorphisms with Dampness-Phlegm Pattern in Korean Stroke Patients.Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohortsNeuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trialUsing reporter gene assays to identify cis regulatory differences between humans and chimpanzeesThe genetics of regulatory variation in the human genomeGenetics of global gene expression.Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial.Prediction of functional regulatory SNPs in monogenic and complex disease.Strong bias in the location of functional promoter polymorphisms.The g.763G>C SNP of the bovine FASN gene affects its promoter activity via Sp-mediated regulation: implications for the bovine lactating mammary gland.Ablation of LMO4 in glutamatergic neurons impairs leptin control of fat metabolism.Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke.Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion.Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4What is a functional genetic polymorphism? Defining classes of functionality.Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence.Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls.Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study.Genetic variation in the neuropeptide Y gene promoter is associated with increased risk of tobacco smoking.Regulatory Single-Nucleotide Variant Predictor Increases Predictive Performance of Functional Regulatory Variants.No association between the -399 C > T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population.Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease
P2860
Q21146079-326FC516-DA1A-4DCA-9353-7139C13977BCQ24538580-921C241B-61D8-4149-A4CF-FC0DE4EB9726Q28485508-BA6A4752-7AD5-4B32-B6D6-20E844579C55Q33257734-1425475A-1A26-4D4B-AFC7-5238D2790551Q33396966-39E33A35-6E59-4349-A1BA-A953E586CE39Q34015548-3399BF82-82B6-41D3-84F4-31CAD6E20778Q34154749-B0786AFF-8F52-4C9B-86F5-51298595AABAQ34462635-6CF7F333-D50C-47AB-92A8-2E4F1186ECDDQ35495020-931ADDF2-0D16-4BFC-BBFE-CC1A159DDA5CQ35597942-828F2E62-6652-46E5-BDE2-D5E8B2EDE533Q35891473-BB9AA1B9-99CE-41ED-8590-497B47A38ECCQ35945654-D04E5259-D66D-428D-AF4A-C2C2578D43EDQ36187200-A25EE135-DDB9-499E-B559-CDE03D00F82EQ36626609-6FBEB261-51B3-43DE-9FD1-E05A41640C7BQ37405891-6E98C19B-0222-4C85-8F29-DF178E6C5CEEQ37643059-A1D675AF-A62C-42AA-A9BB-17D53E85AC04Q38322410-6423440E-FD8F-42D5-9D9E-6E6F44C4FBCCQ39982708-14E478A8-D2F0-440E-8E17-3E1337951CC9Q41001206-9A4969B2-F027-4FEA-A8AE-31CA5D553A1FQ41913773-DA4D34AB-97D9-4820-B8BF-AC453145C38FQ42324839-7644D1CB-3EAA-4A84-A8A3-29B7913BA616Q42410542-2CC6E100-1BD7-43C8-9621-296D7D3502CCQ42949475-023C77C3-0AD4-4D70-B4A9-0CADE35BAE9AQ45946180-F36FB6A4-EA47-4D8E-9CEB-278E38E9B02CQ46611111-CF97AB1C-FF48-45CA-B961-43CB94698F56Q46878590-A89B16A1-9ABA-4477-92E1-5FF34FA982A1Q48513351-DAFE6BE7-02A7-4F92-859D-7BBE3A68F869Q50499209-237A1AC5-BD7E-4DDA-8647-6F0AE43351DEQ50542913-48F7CC2D-9023-428C-AC03-4781B13A1C2AQ58307131-AF4F48D7-3E06-4ED2-B798-9C1663EA6AFF
P2860
A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity
description
article
@en
im November 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2004
@uk
name
A high proportion of polymorph ...... ences transcriptional activity
@en
A high proportion of polymorph ...... ences transcriptional activity
@nl
type
label
A high proportion of polymorph ...... ences transcriptional activity
@en
A high proportion of polymorph ...... ences transcriptional activity
@nl
prefLabel
A high proportion of polymorph ...... ences transcriptional activity
@en
A high proportion of polymorph ...... ences transcriptional activity
@nl
P2093
P50
P1476
A high proportion of polymorph ...... ences transcriptional activity
@en
P2093
Carol A. Guy
Paul R. Buckland
S. Kaye Smith
Sharon L. Coleman
Vahram Haroutunian
P304
P356
10.1016/J.BBADIS.2004.06.023
P577
2004-11-01T00:00:00Z